Covid-19: Oxford University vaccine trial paused after participant falls ill

London: The fight against coronavirus has suffered a major setback. The trial has been suspended after a man involved in a human trial of the AstraZeneca and Oxford University vaccines fell ill.

AstraZeneca said in a statement that it was a routine interruption, as nothing was understood about the person involved in the test.

The vaccine was named AZD1222. According to the World Health Organization, it was at the forefront of other vaccine trials in the world. The eyes of many countries, including India, are fixed on the Oxford University vaccine.

Experts believe that there is a lot of hope that Oxford University will be one of the first vaccines to hit the market.

According to a report, the ongoing trial has been suspended all over the world and can now be resumed only after an independent inquiry. The third phase of the vaccine trial involves around thousands of people and it often takes many years. The third phase trial of the corona vaccine involved about 30,000 people.

A spokesman for the University of Oxford said: "Large trials are more likely to get sick, but independent testing is important for careful screening." This is the second time the trial of the coronavirus vaccine has been stopped at Oxford University.